SoftBank led a $150m Series B+ round in Dingdang Kuaiyao.

SoftBank led a $150m Series B+ round in Dingdang Kuaiyao, a Chinese online-to-offline pharmacy app. The round involved investment from Dingdang Kuaiyao’s previous backers including China Merchants Bank’s investment arm CMB International, and Sinopharm-CICC Capital. "The new round of funding will be mainly used to accelerate the company’s rollout in China’s urban areas, by expanding its service to 10 more cities in mainland China by the end of this year, and covering all of China’s first, second, and third-tier cities in 2021," Yang Wenlong, Dingdang Kuaiyao Founder and CEO.